|
| |
| | | 59322 | | 03.09.2009 | | Sandoz Pharmaceuticals AG | | | | | | | | | | | | | 07.15. | | | | 07.15. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Crilomus 0.5 mg | Kapseln | Capsules (Tacrolimus 0.5 mg) | L04AD02 | CI | | 02 | Crilomus 1 mg | Kapslen | Capsules (Tacrolimus 1 mg) | L04AD02 | CI | | 03 | Crilomus 5 mg | Kapslen | Capsules (Tacrolimus 5 mg) | L04AD02 | CI | | 04 | Crilomus 0.75 mg | Kapslen | Capsules (Tacrolimus 0.75 mg) | L04AD02 | CI | | 05 | Crilomus 2 mg | Kapslen | Capsules (Tacrolimus 2 mg) | L04AD02 | CI |
|
|
|
